Media Contact:
Alexandra Mullane
Marketing & Communications Coordinator
Phone: 212.701.3967
Fax: 212.378.2410
amullane@cahill.com

Firm News

Valeant Pharmaceuticals Completes $365 Million Rule 144A Offering

Date: 06/09/09

Cahill represented UBS Securities LLC and the other initial purchasers in the $365,000,000 Rule 144A Offering by Valeant Pharmaceuticals International of its 8.375% Senior Notes due 2016. The proceeds will be used for general corporate purposes, which may include funding securities repurchases.

Attorney

Media Contact:
Alexandra Mullane
Marketing & Communications Coordinator
Phone: 212.701.3967
Fax: 212.378.2410
amullane@cahill.com